UY30315A1 - Formulacion de medicamento liquida - Google Patents

Formulacion de medicamento liquida

Info

Publication number
UY30315A1
UY30315A1 UY30315A UY30315A UY30315A1 UY 30315 A1 UY30315 A1 UY 30315A1 UY 30315 A UY30315 A UY 30315A UY 30315 A UY30315 A UY 30315A UY 30315 A1 UY30315 A1 UY 30315A1
Authority
UY
Uruguay
Prior art keywords
formulation
medicinal product
liquid medicinal
liquid
animals
Prior art date
Application number
UY30315A
Other languages
English (en)
Inventor
Dr Georg Schulte
Dr Gerald Beddies
Dr Venkata-Rangarao Kanikanti
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of UY30315A1 publication Critical patent/UY30315A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La invencion se refiere a una formulacion de medicamento líquida para betabloqueantes que es especilamente adecuada para la administracion por vía oral en animales.
UY30315A 2006-05-02 2007-04-30 Formulacion de medicamento liquida UY30315A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006020604A DE102006020604A1 (de) 2006-05-02 2006-05-02 Flüssige Arzneimittelformulierung

Publications (1)

Publication Number Publication Date
UY30315A1 true UY30315A1 (es) 2007-11-30

Family

ID=38180418

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30315A UY30315A1 (es) 2006-05-02 2007-04-30 Formulacion de medicamento liquida

Country Status (23)

Country Link
US (1) US20090264535A1 (es)
EP (1) EP2015728A2 (es)
JP (1) JP2009535368A (es)
KR (1) KR20090014183A (es)
CN (1) CN101431981A (es)
AR (1) AR060730A1 (es)
AU (1) AU2007245911A1 (es)
BR (1) BRPI0711140A2 (es)
CA (1) CA2650786A1 (es)
CO (1) CO6180495A2 (es)
CR (1) CR10407A (es)
DE (1) DE102006020604A1 (es)
EC (1) ECSP088850A (es)
GT (1) GT200800235A (es)
IL (1) IL195034A0 (es)
MX (1) MX2008013873A (es)
PE (1) PE20080149A1 (es)
RU (1) RU2008147216A (es)
SV (1) SV2008003080A (es)
TW (1) TW200808373A (es)
UY (1) UY30315A1 (es)
WO (1) WO2007124869A2 (es)
ZA (1) ZA200809269B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011507918A (ja) * 2007-12-27 2011-03-10 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング β−遮断薬を使用する心疾患の処置
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
KR20150120008A (ko) * 2014-04-16 2015-10-27 씨제이헬스케어 주식회사 비소프롤롤 및 로수바스타틴을 포함하는 경구용 약제학적 복합제제
MX2017011257A (es) 2015-03-03 2018-04-10 Saniona As Formulacion de combinacion de tesofensina y betabloqueante.
GB202207690D0 (en) * 2022-05-25 2022-07-06 Zentiva Ks Liquid pharmaceutical formulation of bisoprolol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
US4600708A (en) * 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
ES2293875T3 (es) * 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
US6645963B2 (en) * 1997-11-05 2003-11-11 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
US6664284B2 (en) * 1998-07-23 2003-12-16 Roche Diagnostics Gmbh Stabilized carvedilol injection solution
WO2003028718A1 (en) * 2001-10-01 2003-04-10 Smithkline Beecham Corporation Novel formulations of carvedilol

Also Published As

Publication number Publication date
CR10407A (es) 2009-03-30
US20090264535A1 (en) 2009-10-22
CO6180495A2 (es) 2010-07-19
EP2015728A2 (de) 2009-01-21
KR20090014183A (ko) 2009-02-06
MX2008013873A (es) 2008-11-14
WO2007124869A2 (de) 2007-11-08
ECSP088850A (es) 2008-12-30
IL195034A0 (en) 2009-08-03
DE102006020604A1 (de) 2007-11-08
GT200800235A (es) 2010-04-28
TW200808373A (en) 2008-02-16
RU2008147216A (ru) 2010-06-10
AU2007245911A1 (en) 2007-11-08
WO2007124869A3 (de) 2008-04-17
CA2650786A1 (en) 2007-11-08
BRPI0711140A2 (pt) 2011-08-23
CN101431981A (zh) 2009-05-13
ZA200809269B (en) 2009-12-30
PE20080149A1 (es) 2008-04-06
SV2008003080A (es) 2009-11-26
AR060730A1 (es) 2008-07-10
JP2009535368A (ja) 2009-10-01

Similar Documents

Publication Publication Date Title
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
CL2008001002A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CO6400186A2 (es) Tabletas de acetato de ulipristal
CL2008001003A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
UY31350A1 (es) (carboxilalquilenfenil)feniloxamidas, procedimiento para su preparación y su utilización como medicamentos
BR112015014372A8 (pt) inibidores de autotaxina, seus usos, e composição e combinação farmacêuticas".
BRPI0516238A (pt) composição farmacêutica contendo diclofenaco
CL2012000319A1 (es) Uso de una composición farmaceutica que comprende treprostinil para la preparación de un medicamento para el tratamiento o la prevención de una afección asociada a la fibrosis quística.
ECSP099320A (es) Compuestos de tetrahidropirrolopiracina sustituida y su aplicación en medicamentos
BR112012009376A2 (pt) composição farmacêutica, forma de dosagem farmacêutica, processo para a sua preparação, métodos de tratamento e seu uso
BRPI0517701A (pt) uso de um composto na preparação de medicamentos para o tratamento de diabetes mellitus
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
GT201400059A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos
CL2013003630A1 (es) Formulacion farmaceutica liquida que comprende nitisinona y un tampon de acido citrico que tien un ph en el rango de 2,5 a 3,5, de preferencia 3,0; y su uso para el tratamiento de tirosemia, enfermedad de parkinson, depresion, entre otros.
CR11744A (es) Formulacion liquida para deferiprona con gusto agradable al paladar
NI201000189A (es) Formulación de medicamento sólido con liberación retardadas.
UY30315A1 (es) Formulacion de medicamento liquida
SV2008003018A (es) Formulaciones medicamentosas que contienen fluoroquinolonas
BR112014014795A2 (pt) sistema de pélete de multiunidade de liberação imediata
BRPI0823302A2 (pt) Composição farmacêutica que contém um derivado de n-fenilpirazol, utilização para a preparação de um medicamento veterinário tópico para lutar contra as pulgas
NO20084478L (no) Konjugerte lipidderivater
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
GT200900236A (es) Sales de adición de ácido, hidratos y polimorfos de la etil-amida del ácido 5-(2,4-dihidroxi-5-isopopril-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, y formulaciones que comprenden esta formas.-
MA32635B1 (fr) Produit medicamenteux et traitement associe

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170612